Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.
Genome-Scale Analysis Identifies Novel Genetic Vulnerabilities in Allan Herndon Dudley Syndrome
44 Pages Posted: 4 Oct 2018
More...Abstract
Allan Herndon Dudley syndrome (AHDS), an X-linked condition, constitutes a rare, progressive, clinically heterogeneous disorder involving severe psychomotor retardation and peripheral thyrotoxicosis, consequent to thyroid hormone transporter SLC16A2 mutations. However, direct targeted screening for SLC16A2 mutations in patients with AHDS partly predicts phenotypic heterogeneity although similar mutations are associated with differences in clinical phenotype severity, suggesting the existence of additional gene-related AHDS subtypes as in other types of mental retardation. Specifically, we report a family with AHDS comprising five individuals, including three male children (of whom two were monozygotic twins). In this pedigree, we identified a linkage of two X-linked inherited genes including SLC16A2 (p. G453R) and KIF4A (p. A491V) as a putative AHDS etiology. Additionally, we identified an independent cluster of structural variations (SVs)-enriched potential AHDS susceptibility genes, which might be as the neuronal genetic vulnerabilities likely contributing to AHDS. Our observations suggest that AHDS phenotype heterogeneity may arise from multi-genetic contributions. These familial cases, involving likely novel AHDS subtypes, provide an opportunity to explain neuropsychiatric retardation. An integrated next generation mapping and whole genome sequencing strategy for refining AHDS diagnosis and clinical categorization is recommended inclusive of cases with the related overlapping phenotypes in psychomotor disabilities.
Funding Statement: This work was supported by the Stem Cell Clinical Trial Project of the National Health and Family Planning Commission of China and the China Food and Drug Administration (Registration No. CMR-201611-1003), (Medical Research Registry and Management Systemhttp://114.255.123.14), and the National Nature Science Foundation of China (Grant No. 81471308).
Declaration of Interests: We declare no conflict of interest.
Ethics Approval Statement: Informed consent was obtained from the parents, and the study was approved by the Research Ethics Boards at the First Affiliated Hospital of Dalian Medical University (approval number: YJ-KY-FB-2017-27)
Keywords: Allan Herndon Dudley syndrome (AHDS), Structural Variations, KIF4A, Genetic Susceptibility
Suggested Citation: Suggested Citation